Entity

Orikine bio

Biotechnology - Therapeutics and Diagnostics

Orikine Bio is a biotechnology company specialized in the design and development of bi-specific cytokines for the treatment of autoimmune and inflammatory diseases. Through our proprietary Foldikine™platform, we engineer molecules that act synergistically on specific cell populations, with the goal of maximizing therapeutic efficacy while minimizing the toxicity and adverse effects associated with non-targeted conventional therapies. Orikine Bio is a spin-off from the Centre for Genomic Regulation (CRG) and is financially backed by AdBio Partners and Asabys Partners.

contact@orikine.bio

https://www.orikine.bio


Contact person: Christian Pangratz

Location: Torre D - 04B5